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INTRODUCTION
Appropriate pain management is a topic of cur~ea-at debate. There is ongoing conzoversy regarding the proper use of narc~tic analgesia f~r patients presenting to the emerge1r.c-y department with subjective acnte e:aracerba~ioi.s of pain.'-'! There a-e c reW scientific studies that invesligzte the actilia1 prevalence of adciction in patients frequently . ~ reqmnalg anaslalgesia in the emergency deparrtrnent~"-l 4 More, than 50 rjiilisn Americans suffer from chronic pain th& Y P &~U~~S najcC3li~s foj: j+?ji~ rc~,"ef. 
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We investigated whether the presence of specific factors could be used to identify adiilts corYpPaining of acute exacerbations of pain for suspected drug addiction. 01-K other objectivzs were to estimate the percentage of drug addicted patients, to assess the physicians' ability to detect drug addiction and to evaluate inter-rater reiiabifity.
DAATERIALS AND il4ETHODS
aduh patients compPaining of acute exacehation of ~a i a who presented to the emergency department (ED) were vooluntx~iy recruited for this survey study, as illustrated by the Wow chart in Figure I . The ED is a university-based level I trauma center, with an accredited emergency medicine residency program, &at treats more than 45,000 patients annually. The triage nurse identified potentid s~~bjects for the survey study with the following inclusion criteria: (a) specific narcotic requests, (b) ""allergies" to non-narcotic an~algesics, or (c) 2 or more prior ED visits for similar pain complaints within the past 6 months. Exclusion criteria included any objective pathological or anatomic disease, s~~h as neoplasia, acute trauma, toxic exposure, Section, fiacmre, burn, i d a m a t i o n , isckmk, idxct, peritonitis, hemat010gHc disorder? or specific rheumatologic, efidocrine or ccobgpective tissue disease, or any life-threatening condition. Patknts in exsemis were exciuded, a5 were minors, prisoners, pregnant patients and the mentally hnpahed. For each analgesia szbject, an zge-matched co~-~&ol was enrolled
sex and within 5 years of age.
addiction. Zero indicated "no addiction risk" and 10 '"bsolutely certain addiction." These VAS scores were Consenting subjects completed the self-ad~Miistered later con-elated anonymoersly to the scores from the Drug Abuse Screening Test (DAST-20) distributed DAST-20 in order to assess the ability of the ED by the research personnel from the Emergency physicians to detect drug addiction. Medicine Research Associates Program (EMUP), see Figure 2 . The DAST-20 is a previously validated Data were analyzed using STATA 7.0 (Stata survey tool that measures d-rug addiction via 20 yes/ Corporation, College Station, TX) and results were no questions, exclusive of a l c~h o l . '~ l 8 This reported as counts and percentages with 95% rneas~~rement tool has a specificity of 92%, sensitivity confidence intervals (CI).
of 74 56, positice predictive value of 8396, negative predictive value of 85%, and overall accuracy of 84%, The institutional review board at our center approved as reported by Skinner.'' These dlagnostnc valuec this study protocol under expedited category. with pertain to a DAST-20 cutoff score of 10 which meets the requirement for written consent and distr?~ution the Diagnostic and Statistical Manual of Mental of patient bill of rights to all enrolled subjects. Disorders-Third Edition (DSM-III) criteria for drug addiction.l7.'We used thir same ce~tofZ'vdue. Subjects mSULTS were assured of anonymity and that their DAST-20 scores were blinded horn the treating physic~an. The
The overall estimation of drug addiction among this subjects' ED course was uhindered by the survey. --_-m-. --, m--_---. --. -m--" -
---subjects, 13.5'30 (10134) scored positive for drug addiction by the DAST-20. Wie were unable to find a significant difference between the propofiions (0.135 and 0.21 1) of control and analgesia group subjects with DAST-28 scores of 10 or greater. We were unable to detect a clinicdy relevant d8erence b, Ptween the control and analgesia group DAST-20 scores.
Among the sample population in those subjects who presented to the ED with acute exacerbations of pain, 48.9% (37176) had multiple ED visits, 1 4.8% ( (9176) reported an '6dallergy" to non-narcodcs and 42.1% (321 76) requested specific narcotics for pain control. Thirty-four percent (25176) of the subjects had nnultiple ED visits for acute exacerbations of pain ,and specific narcotic requests.
Positike DAST-20 scores for drug addiction are as follows: (a) 43.8% (7116) for multiple visits, (b) 43.8% (711 6) for specific narcotic requests, and (c) 6.3% ((111 6) for "allergies9' to non-narcotics. The ~~aajoi-ity of patients with a drug addiction problem meacured by the DAST-20 were subjects who reqraected a specific narcotic and those subjects wit11 multiple ED visits for pain control. No single factor or combination offactors was associated with an increased rate of drug addiction as estimated by the DAST-20.
There was no relationship between positive DAST-20 scores for dmg addiction and multiple ED visits, specific narcotic requests or "allergies" to nonnarcotics (p=0.574,0.293 and 0.975, respectively).
There was no correlation between the physician index of suspected drug addiction as measured by the VAS and the estimated rate of drug addiction as measured by the DAST-28 (r=0.833, p=0.70.95% 'GI: -0.430 to 0.194).
We were unable to detect differences between sample subjects with DAST-20 scores of less than I0 (n-60) and those with DAST-28 scores of 10 or greater (n-16) with regad to nmltiple ED visits for acute pain exacerbations (0.50 and 0.4331, "'allergies" to nonnarcotics (0.9 33 and 0.063), or subjects requesting specific narcotics (0.41 7 and 0.438).
DISCUSSION
This is the first prospective st~idy investigating drug addiction among ED patients with acute pain exacerbations. In a recent survey, the majority of physicians reported a great ambivalence concerr~ing controlled drug prescribing: their desire to relieve pain and discomfort along with fear of creating addiction and being inve~tigated by law enforce~nent a~fhorities.~ This dilemma has created much debate regarding tne role of proper pain management in less well-defined pain syndromes usually perceived to have psychosocial components, for example n~yofascial syn&omes, lower back pain. toothache or headache without apparent definitive objective findings.
Clinicians have sought to treat these types of patients wit11 analgesics. The vast majority of these patients do not become addicted. However. at the same time the clinician is trying to minimize those rare patients who do abuse, divert or become addicted.
The DAST-20 was used in this study as a measu~re~nent for drug invol~ement among ED patients presenting with acute exacerbations of pain. The DAST-20 was developed by Skinner in 1 982 to provide a screening device for drug abuse or dependence as defined by DSM-IT6 diagnostic criteria. The study consisted of drug abuse clients at a psychiatricldr~zg treatment center with a known dmg dependel~cy problem. The subjects were pain-free, willing paicipants in the study seeking care for drug depenidency. The data was validated against DSM-%I1 drug abuseldependency criteria. The DAST-20 is only moderately correlated with denial. '
This is the first study to use the DAST-20 as a measurement tool for drug addiction in the primary care setting where the patient is presenting with pain complaints and seeking pain control. The DAST-20 may be ¶awed in that the evduation is of limited value in a drug dependent person who denies drug use. The DAST-20 survey estimated dmg addiction in 17.3%
(2611 50) of the overall study population, 2 I. I ' 3% ( (1 61 '76) in the analgesia group and 4 3.5 5% ( (1 0174) in the control group. These percentages are clinically relevant, indicating that drug addiction exists among patients that present to the ED for acute exacerbations C:i!ifori:i:! Jou:-iii of E;nergei~-~ b'iedici;e ":I: 1 , Jail-Wt:;:. 2965 ---m-----p-.  ----------p~--. -- of pain, as well as in a subset of low-acuity patients that do not present to the ED for a primary complaint of gain management.
The lack of correlation between the DAST-20 scores and the VAS scores implies that ED physician\ are unable to accurately assess drug addiction. However, the attelzdiag VAS scores cowelated wit11 the sum of the three factors (multiple vislts for pain exacerba~ons, \peclfic narcotic reqhlests and ""aPPergies" to nonnarcotics). This suggests that the physician should be aware that patients who present with one or more of these factors may have drug-seeking behaviors.
Tne number of analgesia subjects that were originally approached for the DAST-20 survey was approximately two times the final sample size. The ~najority of the control subjects that were approached for the DAST-20 survey participated in the study. Drug-seeldng for diversion or addiction is potentiall-y a strong motivation for non-participation, A subject that is truly dmg-seeking may be unlikely to admit to that fact even if promised that their admission would not be e~sed "against" them.
The major limitation of this study is the fact that the DAST-26) has not been validated in the ED setting.
For the DAST-20 to be a true gold standard it must be validated in the ED setting for the results to be valid and cfiaapcdly relevant for the estimation of drug addiction.
The second limitation of the study was the sample size. We were underpowered to detect clinically significant differences in drug addiction between the control and analgesia groups. The 39% difference between these two groups for drug addiction (21 5%
vs. 13%) in this study was not clinically significant. By increasing the power (sample size) the type 11 en-or would be decreased, thus minimizing the risk of deciding that no effect or difference exists when inadequate numbers have been examined.
Pdge 7 " the findings may not be generalized to all subjects presenting to the ED with acute exacehations of pain. Lastly denial and under-repo~ting drug involvement would limit the accuracy and re-eliabiliq of the DAST-26) scoreu. This could have ultimately affected the statistical analysis and interpre~ition of our study data.
Many cfinicims I P d c that it is more ethical, if a patient claims pain, to err on the side of pain relief. Others believe that the greater danger lies in creating access to d r~~g s for ab~~sers, diverters. or addicts, which may result in harm to themselves or Such judgments must be made on a case-by-case basis according to the context and the values of the clinician If the physician denies pain mmage~nen?B, the physician has an ethical duty of involving an addiction professional,'' In a recent survey, nearly 4'9% of participating physicians reported having difficulty discussing the issue of the proper use of prescribed niledications with heir patients. ' j Csnf ontation phobia has been well documented in physicians who have been identified with problematic prescfibing patterns, in which the physicians feel acutely uncodoa~ble with confhct and inteqersonal confrontation." l Physician fear and aboidance of confrontation plays into the hands of chemically dependent patients . 9 Newer curricula in medical schools and residency programs have led to an en~phasis on the clinical interview and physician-patient relationskp building skills with an emphasis on rapport-building t e c h n i q~e s .~ Furthermore. by increasing physician ltnowledge about chemical dependence and about chemically dependent patients' abnormal relationships with sckduled drugs, the current practice of underprescribing controlled drugs for persons with medical conditions requiring analgesia may be increased while decreasing the over-prescribing for those whom are chemically dependent, addicted or who divert.y
